Real-World Safety of Trastuzumab Deruxtecan in HER2-Positive Breast Cancer: A Single-Institutional Experience in Korea with Emphasis on ILD and HBV Reactivation

Authors / 作者群

Affiliation / 服務單位

Audio / 音訊檔

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Trastuzumab deruxtecan, HER2-positive breast cancer, Hepatitis B virus reactivation, Interstitial lung disease (ILD)/pneumonitis, Real-world data

Back to list